Showing results (261-270 of 306) with videos related to
Sort By:
Pageof 31
American Journal of Human Genetics|April 2, 2026
Implications of the FDA's new plausible mechanism framework for the development of a personalized in vivo prime editing platformEmily R Feierman, Madelynn N Whittaker, Aidan Quigley, et al.Science (New York, N.Y.)|May 15, 2025
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposaseIsaac P Witte, George D Lampe, Simon Eitzinger, et al.Science (New York, N.Y.)|March 30, 2023
Base editing rescue of spinal muscular atrophy in cells and in miceMandana Arbab, Zaneta Matuszek, Kaitlyn M Kray, et al.Cell|September 1, 2023
Phage-assisted evolution and protein engineering yield compact, efficient prime editorsJordan L Doman, Smriti Pandey, Monica E Neugebauer, et al.Biorxiv : the Preprint Server for Biology|March 22, 2023
A molecular glue approach to control the half-life of CRISPR-based technologiesVedagopuram Sreekanth, Max Jan, Kevin T Zhao, et al.Nature Biotechnology|June 15, 2023
Adenine transversion editors enable precise, efficient A•T-to-C•G base editing in mammalian cells and embryosLiang Chen, Mengjia Hong, Changming Luan, et al.Blood Advances|October 28, 2025
Comparative Analysis of CRISPR-Cas9, lentiviral transduction, and base editing for sickle cell disease in a murine modelHenna Butt, Shruti Sathish, Evan London, et al.Biorxiv : the Preprint Server for Biology|November 14, 2023
Small-molecule binding and sensing with a designed protein familyGyu Rie Lee, Samuel J Pellock, Christoffer Norn, et al.Journal of the American Chemical Society|June 30, 2025
A Molecular Glue Approach to Control the Half-Life of CRISPR-Based TechnologiesVedagopuram Sreekanth, Max Jan, Kevin T Zhao, et al.Nature Communications|August 15, 2023
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoYong Tao, Veronica Lamas, Wan Du, et al.Pageof 31